Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MultiMENDo

Financiado

Menstrual blood multiomics analysis to better diagnose, understand and treat end...

Menstrual blood multiomics analysis to better diagnose, understand and treat endometriosis The MensEndoDiag project aims at finding diagnostic biomarkers and prognostic biomarker candidates, as well as investigating new therapeutic approaches for endometriosis using menstrual fluid, an easily accessible yet overlooked b... ver más

30/04/2028

UPCité

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

UNIVERSITE PARIS CITE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-01-23

ERC-2022-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

2 Participantes

UPCité

1.06M€ | Lider

INSERM

421.27K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Endosolve She Sense: an accurate and non-invasive test that enables si... 2M€ Cerrado

RTC-2015-3821-1 DESARROLLO DE NUEVAS APROXIMACIONES EN EL MANEJO INDIVIDUALI... 724K€ Cerrado

NOVOENDO: PROGRAMA PARA EL DESARROLLO DE BIOM... NOVOENDO: PROGRAMA PARA EL DESARROLLO DE BIOMARCADORES DE IN... 145K€ Cerrado

EUIN2015-62908 USO COMBINADO DE TECNICAS ANALITICAS PARA EL DIAGNOSTICO PRE... 8K€ Cerrado

CPP2021-008440 WOMEC ADVANCED : NUEVAS APROXIMACIONES PARA EL DIAGNÓSTICO D... 534K€ Cerrado

PID2021-127280OB-I00 ATLAS MICROBIANO E INTERACCIONES HUESPED-HOSPEDADOR EN LA PA... 157K€ Cerrado

Duración del proyecto: 63 meses Fecha Inicio: 2023-01-23
Fecha Fin: 2028-04-30

Líder del proyecto

UNIVERSITE PARIS CITE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto The MensEndoDiag project aims at finding diagnostic biomarkers and prognostic biomarker candidates, as well as investigating new therapeutic approaches for endometriosis using menstrual fluid, an easily accessible yet overlooked biological fluid. Endometriosis is a common gynecological disorder affecting 6-10% of women of childbearing age. It is associated with pelvic pain and infertility. It leads to a reduced quality of life and is an economic burden. It is defined by the presence of endometrial tissue outside the uterus. Endometriotic lesion form from retrograde menstruation (menstrual fluid reflux through the fallopian tubes) but the precise pathogenesis remains unclear. There are no noninvasive biomarkers currently used in clinical care but they are essential to improve the diagnosis delay, currently estimated at 8 years. There is no specific treatment and pharmacological options are contraceptive. Here, I propose to use menstrual fluid as a relevant biological fluid for endometriosis. In Aim 1, single-cell transcriptomics and soluble protein multiplex assays on 64 menstrual fluid samples will be used to identify candidate diagnostic biomarkers that differentiate endometriosis affected women from healthy controls. Validation of these biomarkers will be carried out in menstrual fluid samples from 250 women. In Aim 2, menstrual fluid derived organoids cultured with or without immune cells will be used to assess endometriosis associated functional changes and to test new immunomodulatory treatments. In Aim 3, longitudinal cohorts will be established to identify prognostic candidate biomarkers for response to surgery and in vitro fertilization. Diagnostic and prognostic biomarkers are essential to assess disease establishment, evolution and to choose the most appropriate treatment. This project will enhance our understanding of endometriosis pathophysiology as well as allow the study of a new biological fluid, relevant to gynecologic and reproductive disorders.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores